John S. Babcook

1.9k total citations
18 papers, 927 citations indexed

About

John S. Babcook is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John S. Babcook has authored 18 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John S. Babcook's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). John S. Babcook is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (4 papers) and T-cell and B-cell Immunology (4 papers). John S. Babcook collaborates with scholars based in Canada, United States and Australia. John S. Babcook's co-authors include Palaniswami Rathanaswami, Luís Borges, Lara Stepan, Claire L. Sutherland, Esther S. Trueblood, Kari Hale, Kevin B. Leslie, John W. Schrader, Gary R. Fanger and Steven G. Reed and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

John S. Babcook

17 papers receiving 897 citations

Peers

John S. Babcook
Comparison fields: 5 of 77
  • Molecular Biology 361
  • Oncology 276
  • Pulmonary and Respiratory Medicine 249
  • Radiology, Nuclear Medicine and Imaging 230
  • Immunology 164
Brian Cao United States
Amy Ly United States
Silvia Behnke Switzerland
Stefan Störkel Germany
Claudia I. Vidal United States
Derek Atkins Germany
Gary A. Pestano United States
Kelly McGlinchey United States
George R. Gunn United States
Michael A. Linden United States
Brian Cao United States View profile →
Citations per field, relative to John S. Babcook
John S. Babcook · 1×
Citations per year, relative to John S. Babcook
John S. Babcook · 1×

Countries citing papers authored by John S. Babcook

Since Specialization
Citations

This map shows the geographic impact of John S. Babcook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Babcook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Babcook more than expected).

Fields of papers citing papers by John S. Babcook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Babcook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Babcook. The network helps show where John S. Babcook may publish in the future.

Co-authorship network of co-authors of John S. Babcook

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Babcook. A scholar is included among the top collaborators of John S. Babcook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Babcook. John S. Babcook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Title Journal Authors Indexed citations
1 Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2 mAbs Anh Tran, Jegarubee Bavananthasivam et al. 5
2 A novel drug conjugate platform: Redefining the therapeutic window for ADCs Annals of Oncology John S. Babcook, R. H. Davies et al. 1
3 Abstract 3914: ZW49, a HER2-targeted biparatopic antibody-drug conjugate for the treatment of HER2-expressing cancers Cancer Research Kevin J. Hamblett, R. H. Davies et al. 37
4 Abstract 61: Zymelink drug conjugate platform: redefining the therapeutic window for ADCs Cancer Research John S. Babcook, Andrea Hernández et al. 2
5 927 Effective treatment of cisplatin-resistant bladder cancer using a glycosaminoglycan binding malaria protein European Urology Supplements Roland Seiler, Htoo Zarni Oo et al. 1
6 Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy Breast Cancer Research Kimberly Snyder, Michael R. Hughes et al. 56
7 Interleukin‐21 Receptor Blockade Inhibits Secondary Humoral Responses and Halts the Progression of Preestablished Disease in the (NZB × NZW)F1 Systemic Lupus Erythematosus Model Arthritis & Rheumatology Ming Zhang, Gang Yu et al. 28
8 A Pan-Cancer Analysis of Alternative Splicing Events Reveals Novel Tumor-Associated Splice Variants of Matriptase Cancer Informatics Peter Bergqvist, Alireza Heravi‐Moussavi et al. 10
9 Expression of Trop2 Cell Surface Glycoprotein in Normal and Tumor Tissues Journal of Histochemistry & Cytochemistry Lara Stepan, Esther S. Trueblood et al. 179
10 Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms Virology Melissa M. Coughlin, John S. Babcook et al. 24
11 High-affinity binding measurements of antibodies to cell-surface-expressed antigens Analytical Biochemistry Palaniswami Rathanaswami, John S. Babcook et al. 19
12 Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse® Virology Melissa M. Coughlin, Osvaldo Martinez et al. 51
13 Recognition of Human Cytomegalovirus by Human Primary Immunoglobulins Identifies an Innate Foundation to an Adaptive Immune Response The Journal of Immunology Gary R. McLean, Ole Olsen et al. 36
14 Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8 Biochemical and Biophysical Research Communications Palaniswami Rathanaswami, Shelly Roalstad et al. 36
15 Detection of Mammaglobin in the Sera of Patients with Breast Cancer Tumor Biology Gary R. Fanger, Raymond L. Houghton et al. 27
16 P504S The American Journal of Surgical Pathology Zhong Jiang, Bruce A. Woda et al. 295
17 A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities. Proceedings of the National Academy of Sciences John S. Babcook, Kevin B. Leslie et al. 107
18 Automated nonisotopic assay for protein-tyrosine kinase and protein-tyrosine phosphatase activities Analytical Biochemistry John S. Babcook, Julian D. Watts et al. 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026